168 related articles for article (PubMed ID: 20871264)
1. Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population.
Flores RM; Riedel E; Donington JS; Alago W; Ihekweazu U; Krug L; Rosenzweig K; Adusumilli PS; Carbone M; Pass HI
J Thorac Oncol; 2010 Oct; 5(10):1649-54. PubMed ID: 20871264
[TBL] [Abstract][Full Text] [Related]
2. Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients.
Taioli E; Wolf AS; Camacho-Rivera M; Kaufman A; Lee DS; Nicastri D; Rosenzweig K; Flores RM
PLoS One; 2015; 10(12):e0145039. PubMed ID: 26660351
[TBL] [Abstract][Full Text] [Related]
3. Frequency of Surgery in Black Patients with Malignant Pleural Mesothelioma.
Taioli E; Wolf AS; Moline JM; Camacho-Rivera M; Flores RM
Dis Markers; 2015; 2015():282145. PubMed ID: 26063951
[TBL] [Abstract][Full Text] [Related]
4. Survival analysis via nomogram of surgical patients with malignant pleural mesothelioma in the Surveillance, Epidemiology, and End Results database.
Zhuo M; Zheng Q; Chi Y; Jia B; Zhao J; Wu M; An T; Wang Y; Li J; Zhao X; Yang X; Zhong J; Chen H; Dong Z; Wang J; Zhai X; Wang Z
Thorac Cancer; 2019 May; 10(5):1193-1202. PubMed ID: 30951250
[TBL] [Abstract][Full Text] [Related]
5. Malignant pleural mesothelioma: a population-based study of survival.
Milano MT; Zhang H
J Thorac Oncol; 2010 Nov; 5(11):1841-8. PubMed ID: 20975379
[TBL] [Abstract][Full Text] [Related]
6. Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma?
Kim S; Bull DA; Garland L; Khalpey Z; Stea B; Yi S; Hsu CC
Ann Thorac Surg; 2019 Jan; 107(1):194-201. PubMed ID: 30278171
[TBL] [Abstract][Full Text] [Related]
7. Impact of Age on Long-Term Outcomes of Surgery for Malignant Pleural Mesothelioma.
Yang CJ; Yan BW; Meyerhoff RR; Saud SM; Gulack BC; Speicher PJ; Hartwig MG; D'Amico TA; Harpole DH; Berry MF
Clin Lung Cancer; 2016 Sep; 17(5):419-426. PubMed ID: 27236386
[TBL] [Abstract][Full Text] [Related]
8. Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales.
Beckett P; Edwards J; Fennell D; Hubbard R; Woolhouse I; Peake MD
Lung Cancer; 2015 Jun; 88(3):344-8. PubMed ID: 25863904
[TBL] [Abstract][Full Text] [Related]
9. Distinctive clinical characteristics of malignant mesothelioma in young patients.
Thomas A; Chen Y; Yu T; Gill A; Prasad V
Oncotarget; 2015 Jun; 6(18):16766-73. PubMed ID: 26202904
[TBL] [Abstract][Full Text] [Related]
10. Women with malignant pleural mesothelioma have a threefold better survival rate than men.
Taioli E; Wolf AS; Camacho-Rivera M; Flores RM
Ann Thorac Surg; 2014 Sep; 98(3):1020-4. PubMed ID: 24928677
[TBL] [Abstract][Full Text] [Related]
11. Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma.
Nelson DB; Rice DC; Niu J; Atay SM; Vaporciyan AA; Antonoff MB; Hofstetter WL; Walsh GL; Swisher SG; Roth JA; Tsao AS; Gomez DR; Giordano SH; Mehran RJ; Sepesi B
Eur J Cardiothorac Surg; 2018 May; 53(5):960-966. PubMed ID: 29211849
[TBL] [Abstract][Full Text] [Related]
12. Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.
Meyerhoff RR; Yang CF; Speicher PJ; Gulack BC; Hartwig MG; D'Amico TA; Harpole DH; Berry MF
J Surg Res; 2015 Jun; 196(1):23-32. PubMed ID: 25791825
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Survival among Male and Female Patients with Malignant Pleural Mesothelioma: A Random Survival Forest Analysis of Data from the 2000-2017 Surveillance, Epidemiology, and End Results Program.
Liu B; Niu L; Boscoe F; Lee FF
J Registry Manag; 2021; 48(3):118-125. PubMed ID: 35413729
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center.
Flores RM; Zakowski M; Venkatraman E; Krug L; Rosenzweig K; Dycoco J; Lee C; Yeoh C; Bains M; Rusch V
J Thorac Oncol; 2007 Oct; 2(10):957-65. PubMed ID: 17909360
[TBL] [Abstract][Full Text] [Related]
15. [Regional treatment of malignant pleural mesothelioma: results from the tumor centre Regensburg].
Ried M; Speth U; Potzger T; Neu R; Diez C; Klinkhammer-Schalke M; Hofmann HS
Chirurg; 2013 Nov; 84(11):987-93. PubMed ID: 23743993
[TBL] [Abstract][Full Text] [Related]
16. Pediatric, Adolescent and Young Adult (AYA) Peritoneal and Pleural Mesothelioma: A National Cancer Database Review.
Nofi CP; Roberts BK; Rich BS; Glick RD
J Pediatr Surg; 2024 Jun; 59(6):1113-1120. PubMed ID: 38418273
[TBL] [Abstract][Full Text] [Related]
17. Largely Unchanged Annual Incidence and Overall Survival of Pleural Mesothelioma in the USA.
Keshava HB; Tang A; Siddiqui HU; Raja S; Raymond DP; Bribriesco A; Stevenson J; Murthy SC; Ahmad U
World J Surg; 2019 Dec; 43(12):3239-3247. PubMed ID: 31428834
[TBL] [Abstract][Full Text] [Related]
18. Long-Term Survival Outcomes of Cancer-Directed Surgery for Malignant Pleural Mesothelioma: Propensity Score Matching Analysis.
Nelson DB; Rice DC; Niu J; Atay S; Vaporciyan AA; Antonoff M; Hofstetter WL; Walsh GL; Swisher SG; Roth JA; Tsao A; Gomez D; Giordano SH; Mehran R; Sepesi B
J Clin Oncol; 2017 Oct; 35(29):3354-3362. PubMed ID: 28817374
[TBL] [Abstract][Full Text] [Related]
19. Patterns of care and survival among patients with malignant mesothelioma in the United States.
Enewold L; Sharon E; Thomas A
Lung Cancer; 2017 Oct; 112():102-108. PubMed ID: 29191582
[TBL] [Abstract][Full Text] [Related]
20. Role of postoperative radiotherapy in the management of malignant pleural mesothelioma : A propensity score matching of the SEER database.
Abdel-Rahman O
Strahlenther Onkol; 2017 Apr; 193(4):276-284. PubMed ID: 28044200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
